| Compound name | Brutto | MW | CAS | PubChem CID | Action | Reference | Reference |
|---|---|---|---|---|---|---|---|
| SL0101-1 | C25H24O12 | 516.46 | 77307-50-7 | 10459196 | RSK | Smith (2005) Cancer Res. 65 1027 | Goden Sayeski (2006) Am. J. Cell. Physiol. 291 1308 |
| Kinase | % Activity Remaining | Standard Deviation |
|---|---|---|
| AMPK | 88 | 0 |
| Aurora B | 45 | 6 |
| Aurora C | 76 | 2 |
| BRSK2 | 80 | 4 |
| CAMK1 | 105 | 7 |
| CAMKK alpha | 116 | 9 |
| CAMKK beta | 107 | 7 |
| CDK2-Cyclin A | 106 | 5 |
| CHK1 | 82 | 0 |
| CHK2 | 98 | 2 |
| CK1 delta | 87 | 1 |
| CK2 | 101 | 6 |
| CSK | 105 | 6 |
| DYRK1A | 79 | 6 |
| DYRK2 | 89 | 4 |
| DYRK3 | 84 | 3 |
| EF2K | 85 | 4 |
| ERK1 | 98 | 5 |
| ERK2 | 98 | 9 |
| ERK8 | 89 | 9 |
| GSK3 beta | 87 | 11 |
| HIPK2 | 72 | 8 |
| HIPK3 | 109 | 7 |
| IKK beta | 99 | 2 |
| JNK1 | 94 | 9 |
| JNK2 | 94 | 7 |
| JNK3 | 97 | 2 |
| Lck | 88 | 0 |
| MAPKAP-K2 | 95 | 3 |
| MAPKAP-K3 | 111 | 12 |
| MARK3 | 112 | 6 |
| MELK | 102 | 6 |
| MKK1 | 88 | 7 |
| MNK1 | 82 | 0 |
| MNK2 | 96 | 6 |
| MSK1 | 101 | 1 |
| MST2 | 98 | 1 |
| NEK2a | 101 | 8 |
| NEK6 | 108 | 13 |
| NEK7 | 104 | 0 |
| p38 alpha MAPK | 94 | 8 |
| p38 beta MAPK | 98 | 1 |
| p38 delta MAPK | 88 | 10 |
| p38 gamma MAPK | 103 | 8 |
| PAK4 | 95 | 5 |
| PAK5 | 85 | 5 |
| PAK6 | 126 | 9 |
| PDK1 | 102 | 8 |
| PHK | 96 | 5 |
| PIM1 | 71 | 2 |
| PIM2 | 95 | 1 |
| PIM3 | 49 | 2 |
| PKA | 92 | 7 |
| PKB alpha | 88 | 7 |
| PKB beta | 98 | 4 |
| PKC alpha | 90 | 6 |
| PKC zeta | 81 | 2 |
| PKD1 | 88 | 3 |
| PLK1 | 111 | 11 |
| PRAK | 82 | 3 |
| PRK2 | 106 | 7 |
| ROCK 2 | 109 | 4 |
| RSK1 | 23 | 1 |
| RSK2 | 30 | 5 |
| S6K1 | 103 | 8 |
| SGK1 | 109 | 10 |
| SmMLCK | 109 | 4 |
| Src | 104 | 3 |
| SRPK1 | 95 | 4 |